Lol, he was a classic, The Strategist, will NEVER forget the one where Mark Smith took him on a bus tour of MtP, with pics, someone turned the dorm lights out after this monstrous effort.
Molycorp: A Second Chance: Part III of III
Jan. 12, 2012
For the convenience of Seeking Alpha readers, we have divided this report into three parts:
Base Case Model Snapshot
- Our Macro Perspective on the REE Sector
- Molycorp: Understanding the Misunderstood
- Valuation: Putting it All Together
Our analysis suggests that Molycorp is conservatively worth $139/share on a net present value basis at the end of 2012. This is derived from our base case scenario outlined in this report. We have also ran a severely bearish scenarios to illustrate why even if we adopt a more conservative price deck, Molycorp is undervalued. In both scenarios, we have assumed the acceleration of Project Phoenix does not occur and that the original time table (Phase I commence Jan. 2013, Phase II commence Jan. 2014)
https://seekingalpha.com/article/319144-molycorp-a-second-chance-part-iii-of-iii
ausheds
Comments1168 | Following
Moly starting to come clean on costs with MS now stating $10/12kg with Phase 1 and that remains to be proven out in the desert. Hard to see their CoGen & acid plant bringing that back to anything like their claimed COP, should they find the money to build them.
Probably time for a little update on your "conservative" $139 valuation year end I'm thinking. Moving the decimal point to the left should do it nicely.
03 Aug 2012, 08:40 PM Edit/Delete
ausheds
Comments1168 | Following
Sorry, was a touch over optimistic, will probably need to move that decimal point two notches.
Any update forthcoming?
17 Aug 2012, 11:11 AM Edit/DeleteReply0Like
- Forums
- ASX - By Stock
- LYC
- Share Price/Charts
Share Price/Charts, page-65
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.14 |
Change
-0.200(2.72%) |
Mkt cap ! $6.673B |
Open | High | Low | Value | Volume |
$7.34 | $7.34 | $7.13 | $39.28M | 5.467M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1546 | $7.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.15 | 72361 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25876 | 7.120 |
2 | 280 | 7.110 |
4 | 14033 | 7.100 |
2 | 77850 | 7.090 |
2 | 13233 | 7.080 |
Price($) | Vol. | No. |
---|---|---|
7.150 | 72361 | 6 |
7.160 | 1420 | 1 |
7.170 | 10329 | 1 |
7.180 | 10329 | 1 |
7.190 | 10329 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online